JAGUAR HEALTH, INC. Deferred Tax and Other Liabilities, Noncurrent
JAGUAR HEALTH, INC. (JAGX) had Deferred Tax and Other Liabilities, Noncurrent of $986.00 thousand as of 2025-12-31, per its 10-K filed 2026-04-07.
Financial Statements › Notes › Other Liabilities
us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent · last filed 2026-04-07
- 2025-12-31: Deferred Tax and Other Liabilities, Noncurrent $986.00K.
- 2024-12-31: Deferred Tax and Other Liabilities, Noncurrent $545.00K.
- 2023-12-31: Deferred Tax and Other Liabilities, Noncurrent $1.43M.
- 2022-12-31: Deferred Tax and Other Liabilities, Noncurrent $566.00K.
| Period end | Deferred Tax and Other Liabilities, Noncurrent | Deferred Tax and Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2025-12-31 | $986.00K 10-K · filed 2026-04-07 | |
| 2024-12-31 | $545.00K 10-K · filed 2026-04-07 | |
| 2023-12-31 | $1.43M 10-K · filed 2025-03-31 | |
| 2022-12-31 | $566.00K 10-K · filed 2024-04-01 | |
| 2021-12-31 | $678.00K 10-K · filed 2023-03-24 | |
| 2019-12-31 | $21.00 10-K · filed 2021-03-31 | $20.59K 10-K · filed 2020-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |